GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Shedir Pharma Group SpA (MIL:SHE) » Definitions » EV-to-EBITDA

Shedir Pharma Group SpA (MIL:SHE) EV-to-EBITDA : 3.77 (As of Jun. 01, 2025)


View and export this data going back to 2019. Start your Free Trial

What is Shedir Pharma Group SpA EV-to-EBITDA?

EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Shedir Pharma Group SpA's enterprise value is €47.75 Mil. Shedir Pharma Group SpA's EBITDA for the trailing twelve months (TTM) ended in Jun. 2024 was €12.68 Mil. Therefore, Shedir Pharma Group SpA's EV-to-EBITDA for today is 3.77.

The historical rank and industry rank for Shedir Pharma Group SpA's EV-to-EBITDA or its related term are showing as below:

MIL:SHE' s EV-to-EBITDA Range Over the Past 10 Years
Min: 2.95   Med: 4.66   Max: 12.51
Current: 3.77

During the past 7 years, the highest EV-to-EBITDA of Shedir Pharma Group SpA was 12.51. The lowest was 2.95. And the median was 4.66.

MIL:SHE's EV-to-EBITDA is not ranked
in the Drug Manufacturers industry.
Industry Median: 13.98 vs MIL:SHE: 3.77

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2025-06-01), Shedir Pharma Group SpA's stock price is €4.88. Shedir Pharma Group SpA's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2024 was €0.535. Therefore, Shedir Pharma Group SpA's PE Ratio (TTM) for today is 9.12.

The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio (TTM).


Shedir Pharma Group SpA EV-to-EBITDA Historical Data

The historical data trend for Shedir Pharma Group SpA's EV-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shedir Pharma Group SpA EV-to-EBITDA Chart

Shedir Pharma Group SpA Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-EBITDA
Get a 7-Day Free Trial 12.23 5.60 5.48 3.27 4.35

Shedir Pharma Group SpA Semi-Annual Data
Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
EV-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 3.27 - 4.35 -

Competitive Comparison of Shedir Pharma Group SpA's EV-to-EBITDA

For the Drug Manufacturers - Specialty & Generic subindustry, Shedir Pharma Group SpA's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Shedir Pharma Group SpA's EV-to-EBITDA Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Shedir Pharma Group SpA's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Shedir Pharma Group SpA's EV-to-EBITDA falls into.


;
;

Shedir Pharma Group SpA EV-to-EBITDA Calculation

Shedir Pharma Group SpA's EV-to-EBITDA for today is calculated as:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA (TTM)
=47.754/12.683
=3.77

Shedir Pharma Group SpA's current Enterprise Value is €47.75 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Shedir Pharma Group SpA's EBITDA for the trailing twelve months (TTM) ended in Jun. 2024 was €12.68 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Shedir Pharma Group SpA  (MIL:SHE) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

Shedir Pharma Group SpA's PE Ratio (TTM) for today is calculated as:

PE Ratio (TTM)=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=4.88/0.535
=9.12

Shedir Pharma Group SpA's share price for today is €4.88.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Shedir Pharma Group SpA's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2024 was €0.535.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio (TTM).

Please read Which price ratio outperforms the enterprise multiple?


Shedir Pharma Group SpA EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Shedir Pharma Group SpA's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


Shedir Pharma Group SpA Business Description

Traded in Other Exchanges
N/A
Address
95 - Piano di Sorrento, Via Bagnulo, Naples, ITA, 80063
Shedir Pharma Group SpA is engaged in manufacturing of nutraceuticals, cosmetics and medical devices. Its products are divided into four lines Shedir , Deimos, Phobos, and Menkar. The company's products include capsules, softgels, swallowable and chewable tablets, orosoluble powders, granules, oral solutions, drops for oral use, sprays for oral, sublingual and nasal use, Creams and gels for cosmetic use, and Spray for topical use.

Shedir Pharma Group SpA Headlines